Peter Maag, Ph.D., is the CEO of Kyverna Therapeutics. Dr. Maag is a seasoned global industry executive with a track record of transforming organizations and more than 20 years of executive management experience in the pharmaceutical and diagnostic industries.
Prior to joining Kyverna, Dr. Maag was Executive Chairman, President and CEO of CareDx, where he built the company from a small start-up into a public company and industry-leading powerhouse in transplantation through a series of BD&L and financing transactions. Prior to joining CareDx in 2012, Dr. Maag held multiple positions at Novartis with increasing responsibilities and worked at McKinsey & Company in New Jersey and Germany.
Dr. Maag received his Ph.D. from the University of Berlin, Germany, and studied pharmaceutical sciences in Heidelberg and London.